Gufic BioScience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
294.35
1.85 (0.63%)
BSENSE

Mar 20

BSE+NSE Vol: 34.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
231.41
237.05
223.72
205.02
207.79
204.18
202.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
231.41
237.05
223.72
205.02
207.79
204.18
202.81
Raw Material Cost
99.27
113.47
88.52
122.91
73.59
74.93
72.77
Purchase of Finished goods
15.82
25.69
14.27
10.85
15.55
16.57
12.45
(Increase) / Decrease In Stocks
-14.07
-34.72
-2.01
-44.09
5.03
4.62
9.53
Employee Cost
40.09
37.45
36.00
35.57
33.96
28.47
29.05
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
0.00
0.00
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
57.32
57.32
53.65
53.41
45.74
40.96
43.24
Total Expenditure (Excl Depreciation)
198.43
199.21
190.42
178.65
173.87
165.56
167.03
Operating Profit (PBDIT) excl Other Income
32.98
37.84
33.30
26.37
33.92
38.62
35.78
Other Income
0.79
2.12
0.93
0.39
1.86
0.11
1.25
Operating Profit (PBDIT)
33.77
39.96
34.23
26.76
35.78
38.73
37.03
Interest
8.36
9.58
9.23
8.40
4.91
5.18
4.62
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
25.41
30.38
25.00
18.36
30.87
33.55
32.41
Depreciation
7.69
7.77
7.72
7.84
4.62
4.30
4.31
Profit Before Tax
17.72
22.60
17.27
10.52
26.26
29.25
28.10
Tax
5.30
5.78
4.20
2.81
6.96
7.49
7.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.42
16.82
13.07
7.72
19.31
21.77
20.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.42
16.82
13.07
7.72
19.31
21.77
20.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
12.42
16.82
13.07
7.72
19.31
21.77
20.86
Equity Capital
10.03
10.03
10.03
10.03
10.03
10.03
10.03
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
1.24
1.68
1.3
0.77
1.93
2.17
2.08
Diluted Earnings per share
1.24
1.68
1.3
0.77
1.93
2.17
2.08
Operating Profit Margin (Excl OI)
14.25%
15.96%
14.88%
12.86%
16.32%
18.91%
17.64%
Gross Profit Margin
10.98%
12.82%
11.17%
8.96%
14.86%
16.43%
15.98%
PAT Margin
5.37%
7.1%
5.84%
3.77%
9.29%
10.66%
10.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -2.38% vs 5.96% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -26.16% vs 28.69% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -12.84% vs 13.63% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -12.73% vs 3.79% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Gufic BioScience With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
231.41
0
231.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
231.41
0
231.41
Raw Material Cost
99.27
0
99.27
Purchase of Finished goods
15.82
0
15.82
(Increase) / Decrease In Stocks
-14.07
0
-14.07
Employee Cost
40.09
0
40.09
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
57.32
0.00
57.32
Total Expenditure (Excl Depreciation)
198.43
0
198.43
Operating Profit (PBDIT) excl Other Income
32.98
0.00
32.98
Other Income
0.79
0
0.79
Operating Profit (PBDIT)
33.77
0
33.77
Interest
8.36
0
8.36
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
25.41
0
25.41
Depreciation
7.69
0
7.69
Profit Before Tax
17.72
0
17.72
Tax
5.30
0
5.30
Provisions and contingencies
0.00
0
0.00
Profit After Tax
12.42
0
12.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
12.42
0
12.42
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.42
0
12.42
Equity Capital
10.03
0
10.03
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
1.24
0
1.24
Diluted Earnings per share
1.24
0
1.24
Operating Profit Margin (Excl OI)
14.25%
0%
0.00
14.25%
Gross Profit Margin
10.98%
0%
0.00
10.98%
PAT Margin
5.37%
0%
0.00
5.37%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 231.41 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.38% vs 5.96% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 11.37% vs 2.98% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.42 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -26.16% vs 28.69% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -35.68% vs -13.25% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.98 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -12.84% vs 13.63% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -2.77% vs -6.97% in Dec 2024

Quarterly - Interest
Interest 8.36 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -12.73% vs 3.79% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 70.26% vs 54.40% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.25%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024